主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RANI
#3426
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.72%
每月变动
-0.72%
6个月变化
+140.35%
年变化
-8.67%
前一天收盘价
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
交易量
19
市场
股票
医疗保健
RANI
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
29.81 M
33.51 M
33.57 M
47.9 M
97.54 M
—
Valuation ratios
Enterprise value
—
312.74 M
—
67.23 M
121.43 M
—
Price to earnings ratio
-1.21
-1.3
-1.21
-0.53
-0.58
-3.62
Price to sales ratio
—
0.04
—
—
0.01
—
Price to cash flow ratio
-1.43
-1.1
-1.05
-0.5
-0.59
-3.24
Price to book ratio
2.13
19.58
6.23
-7.85
-1.3
16.66
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.24
0.3
0.4
0.53
1.48
Return on equity %
1.17
2.56
1.36
0.73
0.45
5.1
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
—
—
—
Operating margin %
—
1 454.96
6 984.3
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
870.33
4 223.26
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.6
1.5
0.88
0.54
0.26
3.17
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.03
0.01
0
0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.31
0.26
0.25
0.13
0
0.64
Long term debt to total equity ratio
4.34
4.83
1.94
0.4
0
7.16
Per share metrics
Operating cash flow per share
0.31
0.3
0.24
0.16
0.11
0.81
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.16
0.13
0.3
0.28
0.09
0.8
Net current asset value per share
1.2
1.04
0.53
0.3
0.11
1.99
Tangible book value per share
0.11
0.07
0.09
0.15
0.17
0.48
Working capital per share
0.45
0.35
-0.07
-0.26
-0.31
-0.29
Book value per share
0.12
0.07
0.09
0.15
0.17
0.48
新闻
Rani Therapeutics任命Alireza Javadi为首席技术官
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics修改公司章程,降低B类股投票权并终止税务协议
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics宣布与中外制药达成价值10.85亿美元合作协议
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
美国股市上涨;截至收盘道琼斯工业平均指数上涨0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Rani Therapeutics董事Imran Mir A购入价值126万美元股票
Rani Therapeutics director Imran Mir a buys $1.26 million in stock